William Blair & Company’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,444
| Closed | -$31.3K | – | 1790 |
|
|
2023
Q3 | $31.3K | Sell |
10,444
-5
| -0% | -$15 | ﹤0.01% | 1635 |
|
|
2023
Q2 | $39.1K | Sell |
10,449
-5
| -0% | -$19 | ﹤0.01% | 1624 |
|
|
2023
Q1 | $35K | Sell |
10,454
-4
| -0% | -$13 | ﹤0.01% | 1629 |
|
|
2022
Q4 | $50.3K | Buy |
+10,458
| New | +$50.3K | ﹤0.01% | 1574 |
|
|
2022
Q3 | – | Sell |
-14,439
| Closed | -$103K | – | 1821 |
|
|
2022
Q2 | $103K | Buy |
+14,439
| New | +$103K | ﹤0.01% | 1538 |
|
|
2022
Q1 | – | Sell |
-28,869
| Closed | -$258K | – | 1911 |
|
|
2021
Q4 | $258K | Sell |
28,869
-53,944
| -65% | -$482K | ﹤0.01% | 1475 |
|
|
2021
Q3 | $2.9M | Buy |
82,813
+57,395
| +226% | +$2.01M | 0.01% | 603 |
|
|
2021
Q2 | $546K | Buy |
25,418
+16,438
| +183% | +$353K | ﹤0.01% | 1123 |
|
|
2021
Q1 | $555K | Buy |
8,980
+3,650
| +68% | +$226K | ﹤0.01% | 1082 |
|
|
2020
Q4 | $223K | Buy |
+5,330
| New | +$223K | ﹤0.01% | 1384 |
|